Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
Thumbnail

Heart surgeons are fed up with old technology—many have considered a career change

A majority of U.S. surgeons, including those who treat heart patients on a daily basis, say their operating rooms use outdated technology. It is having a negative impact on patient care. 

cannabis use disorder marijuana joint weed smoking

Risk of death from CVD skyrockets when women use cannabis

“While the use of cannabis continues to gain popularity, its broader effects on public health within the general population are not yet fully understood,” one researcher said.

Vivek Reddy, MD, Director, Cardiac Arrhythmia Service, and the Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology, at Mount Sinai in New York, was involved in most of the late-breaking pulsed field ablation (PFA) trials at the Heart Rhythm Society (HRS) 2024 meeting. He offers an overview of the new data presented and his observations from using PFA. #HRS24 #HRS2024 #PFA #EPeeps

The future of electrophysiology: Reviewing key trends in PFA

Vivek Reddy, MD, was involved in most of the late-breaking pulsed field ablation trials at Heart Rhythm 2024. He spoke to Cardiovascular Business at the conference about those trials and what they mean going forward.

Thumbnail

How having ovaries removed before menopause affects brain structure

These changes are especially prevalent in women who have the surgery before the age of 40, new research suggests. 

artificial intelligence in cardiology

AI can help cardiologists predict death after TAVR—but there is a catch

It's clear that advanced AI algorithms will radically transform care for TAVR patients in the years ahead. For now, however, certain AI models may require too much data to be helpful on a consistent basis. 

Elutia, a Maryland-based healthcare technology company, has received clearance from the U.S. Food and Drug Administration (FDA) for EluPro, its new biologic envelope specifically designed for patients with implantable pacemakers and defibrillators. It was also cleared for use when implanting other types of devices, including neurostimulators and neuromodulators.

FDA clears new drug-eluting envelope for implantable cardiac devices—CEO sees it as ‘tip of the iceberg’

Elutia, formerly known as Aziyo Biologics, is already targeting additional uses for the newly approved device. 

Thumbnail

The waiting game: Delaying TAVR increases healthcare costs by $10K per year

Delaying TAVR in eligible patients with severe AS can lead to much higher healthcare costs, according to a new study of real-world Medicare data.

Peter Monteleone, MD, an interventional cardiologist, national director of cardiovascular research at Ascension Health, and assistant professor, UT Austin Dell School of Medicine, explained the use of artificial intelligence (AI) to independently identify an emergency stroke or pulmonary embolism (PE) finding on a CT scan and automatically alert critical care team members. His health system uses this type of AI for earlier activation of the pulmonary embolism response team (PERT).

AI critical care software revolutionizes emergency response

Ascension Health in Texas uses AI that can read CT scans for stroke and pulmonary embolism to activate care teams before the images even get into the PACS.

Displaying 961 - 968 of 6427
Design by Adaptive Theme